These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6417009)

  • 1. SB types of HLA-D homozygous typing cells.
    Wernet P; Shaw S; Brautbar C; Westphal E; Pawelec G
    Immunogenetics; 1983; 18(5):547-51. PubMed ID: 6417009
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterogeneity of class II histocompatibility antigens isolated from a human lymphoblastoid B cell line homozygous at the HLA loci (HLA-A3, 3; B7, 7; Dw2, 2; DR2,2; DC1,1; MB1,1; MT1,1).
    Kratzin H; Yang CY; Götz H; Thinnes FP; Kruse T; Egert G; Pauly E; Kölbel S; Wernet P; Hilschmann N
    Hum Immunol; 1983 Sep; 8(1):65-73. PubMed ID: 6415000
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of HLA-D/DR-related DNA polymorphism in HLA-D homozygous typing cells.
    Owerbach D; Lernmark A; Rask L; Peterson PA; Platz P; Svejgaard A
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3758-61. PubMed ID: 6304735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of T-lymphoblast-encoded HLA-DR, MT, and SB antigens on human T-B lymphoblast hybrids.
    Howell DN; Hartzman RJ; Cresswell P
    Hum Immunol; 1983 Oct; 8(2):167-75. PubMed ID: 6417070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic identification of the human secondary B cell antigens. Correlations between function, genetics, and structure.
    Shaw S; DeMars R; Schlossman SF; Smith PL; Lampson LA; Nadler LM
    J Exp Med; 1982 Sep; 156(3):731-43. PubMed ID: 6809881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell clones with similar antigen specificity may be restricted by DR, MT(DC), or SB class II HLA molecules.
    Qvigstad E; Moen T; Thorsby E
    Immunogenetics; 1984; 19(5):455-60. PubMed ID: 6427104
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic mapping of a human class II antigen beta-chain cDNA clone to the SB region of the HLA complex.
    Roux-Dosseto M; Auffray C; Lillie JW; Boss JM; Cohen D; DeMars R; Mawas C; Seidman JG; Strominger JL
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6036-40. PubMed ID: 6310612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MT3 specificity resides on a novel human class II antigen distinct from the HLA-DR antigen and DC-like antigen.
    Yabe T; Suzuki M; Satake M; Juji T; Hamaguchi H
    Immunogenetics; 1984; 20(2):155-67. PubMed ID: 6205988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping SB in relation to HLA and GLO1 using cells from first-cousin marriage offspring.
    Termijtelen A; Meera Khan P; Shaw S; van Rood JJ
    Immunogenetics; 1983; 18(5):503-12. PubMed ID: 6417008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complexity of HLA-DS molecules. A homozygous cell line expresses multiple HLA-DS alpha chains.
    Karr RW; Alber C; Goyert SM; Silver J; Duquesnoy RJ
    J Exp Med; 1984 May; 159(5):1512-31. PubMed ID: 6425448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophoretic analysis of human HLA-DR antigens from HLA-DR4 homozygous cell lines: correlation between beta-chain diversity and HLA-D.
    Nepom BS; Nepom GT; Mickelson E; Antonelli P; Hansen JA
    Proc Natl Acad Sci U S A; 1983 Nov; 80(22):6962-6. PubMed ID: 6417660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for V beta restricted recognition of HLA-DR alleles.
    Kotb M; Lobashevsky A; Guedez Y; Gaber AO
    Transplant Proc; 1997; 29(1-2):1005-7. PubMed ID: 9123171
    [No Abstract]   [Full Text] [Related]  

  • 15. HLA-D/DR restriction of proliferative T cell responses to antigen. Enrichment of antigen-specific T cell blasts and evidence of preferential HLA-D/DR restriction.
    Berle EJ; Thoresen AB; Thorsby E
    Tissue Antigens; 1982 Nov; 20(5):380-8. PubMed ID: 6186050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses.
    Shaw S; Johnson AH; Shearer GM
    J Exp Med; 1980 Sep; 152(3):565-80. PubMed ID: 6967946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR compatibility in couples with recurrent spontaneous abortions.
    Aoki K
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Oct; 34(10):1773-80. PubMed ID: 6816873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.
    Scholl P; Diez A; Mourad W; Parsonnet J; Geha RS; Chatila T
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4210-4. PubMed ID: 2542966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SB-restricted presentation of influenza and herpes simplex virus antigens to human T-lymphocyte clones.
    Eckels DD; Lake P; Lamb JR; Johnson AH; Shaw S; Woody JN; Hartzman RJ
    Nature; 1983 Feb; 301(5902):716-8. PubMed ID: 6186920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic organization and polymorphism of the HLA-D region].
    Guilherme L; Colombani M; Sansonetti N; Colombani J
    Ann Immunol (Paris); 1983; 134C(1):3-24. PubMed ID: 6190429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.